About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

With

National Institute of Mental Health (NIMH)

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with a diagnosis of Major Depressive Disorder, currently depressed without psychotic features
Females must be of non-childbearing potential.

You may not be if

Treatment with Clozapine or ECT within 3 months prior to study
Current or past history of psychotic features or a diagnosis of schizophrenia or any other psychotic disorder as defined in the DSM-IV

The record

StatusCompleted

PhasePhase 2

Taking part22

StartedDec 2009

UpdatedOct 21, 2014

Conditions

Treatment Resistant Major Depressive Disorder

Where1

Research Site
Bethesda, Maryland, United States

Clareo Health | This is a Study to Determine the Antidepressant Effects of AZD6765